Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2015

Feb 10, 2015

30597_dirs_2015-02-10_a3e763fc-d410-49df-a87e-8b1a483905a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2015-02-09

Reporting Person: WYZGA MICHAEL S (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-09 Stock Option (right to buy) $26.98 A 12608 Acquired 2025-02-09 Common Stock (12608) Direct

Footnotes

F1: This option vests in three equal annual installments beginning on the first anniversary of the date of grant.